| Website | limerickbio.com |
| Category | BioTech |
| Phone | 650-742-0110 |
| mailbox@limerickb... | |
| Employees | |
| Founded | 2004 |
| Description | Compound Developer |
| TOTAL | $31.7M |
| FUNDING TOTAL | $31.7M |
| Venture Round, 6/08 ARCH Venture Partners Sevin Rosen Funds Altitude Life Science Ventures | $15.2M |
| Series A, 6/09 | $1.5M |
| Series C, 7/09 ARCH Venture Partners Sevin Rosen Funds Altitude Life Science Ventures | $15M |
| DEBT TOTAL | $3.59M |
| Debt, 12/10 | $3.59M |
Limerick BioPharma is dedicated to developing compounds that, when used adjunctively with both marketed and investigational drugs, significantly improve the quality of patients’ lives. Their compounds minimize toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug’s desired effects. In the monotherapy setting, they are developing novel compounds that target the treatment of metabolic diseases such as hypercholesteremia and hyperglycemia.
